• 1. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 2. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587
• 3. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 4. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480
• 5. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584

Introduction to N-(3-Methylbutan-2-yl)cyclopropanamine (CAS No. 926204-43-5)

N-(3-Methylbutan-2-yl)cyclopropanamine, a compound with the chemical formula C?H??N, is a significant molecule in the field of pharmaceutical chemistry and bioorganic synthesis. This compound, identified by its CAS number 926204-43-5, has garnered attention due to its unique structural properties and potential applications in drug development. The presence of a cyclopropane ring and an N-substituted aliphatic chain makes it a versatile intermediate for various synthetic pathways.

The structural motif of N-(3-Methylbutan-2-yl)cyclopropanamine includes a cyclopropane ring, which is known for its high ring strain and reactivity. This characteristic allows the compound to participate in various chemical transformations, making it valuable in synthetic organic chemistry. Additionally, the N-substituent at the 2-position of the 3-methylbutyl chain introduces a nitrogen atom that can engage in hydrogen bonding or coordinate with metal centers, further enhancing its utility in medicinal chemistry.

In recent years, there has been a growing interest in cyclopropane-containing compounds due to their biological activity. Research has demonstrated that cyclopropane rings can enhance the binding affinity of molecules to biological targets, making them attractive for drug design. N-(3-Methylbutan-2-yl)cyclopropanamine, with its cyclopropane core, represents a promising scaffold for developing novel therapeutic agents.

One of the most compelling aspects of N-(3-Methylbutan-2-yl)cyclopropanamine is its potential role as a building block in the synthesis of more complex molecules. The compound's reactivity allows for facile functionalization at multiple sites, enabling chemists to construct intricate structures with precision. This property is particularly valuable in the context of drug discovery, where the ability to modify molecular architecture is crucial for optimizing pharmacological properties.

Recent studies have explored the use of N-(3-Methylbutan-2-yl)cyclopropanamine in the development of bioactive molecules. For instance, researchers have investigated its incorporation into peptidomimetics and small-molecule inhibitors. These studies highlight the compound's versatility and its potential to contribute to the discovery of new drugs targeting various diseases.

The synthesis of N-(3-Methylbutan-2-yl)cyclopropanamine involves several key steps that showcase modern organic synthesis techniques. The introduction of the cyclopropane ring can be achieved through ring-closing metathesis (RCM) or other cycloaddition reactions. The subsequent functionalization of the 3-methylbutyl chain and the nitrogen atom provides opportunities for further diversification. These synthetic strategies underscore the compound's importance as a synthetic intermediate.

In addition to its synthetic utility, N-(3-Methylbutan-2-yl)cyclopropanamine has shown promise in preclinical studies as a lead compound for drug development. Its unique structural features make it an attractive candidate for further investigation into potential therapeutic applications. Researchers are exploring its interactions with biological targets such as enzymes and receptors, which could lead to novel treatments for various conditions.

The pharmaceutical industry continues to seek innovative compounds that can address unmet medical needs. N-(3-Methylbutan-2-yl)cyclopropanamine, with its distinctive chemical profile, stands out as a compound worthy of further exploration. Its potential applications in drug discovery and synthetic chemistry make it a valuable asset in the quest for new therapeutic agents.

As research progresses, it is expected that more insights into the biological activity and synthetic utility of N-(3-Methylbutan-2-yl)cyclopropanamine will emerge. The continued investigation of this compound will likely contribute to advancements in medicinal chemistry and provide new opportunities for therapeutic intervention. The intersection of organic synthesis and pharmacology will remain a fertile ground for innovation, with compounds like N-(3-Methylbutan-2-yl)cyclopropanamine playing a pivotal role.

• 39190-94-8((1,2-dimethylpropyl)propylamine)
• 1016860-05-1(N-(1-Cyclopropylethyl)propan-1-amine)
• 1093403-67-8(N-(1,2-dimethylpropyl)cyclopropanamine;hydrochloride)
• 1019561-65-9((1-cyclopropylethyl)(cyclopropylmethyl)amine)
• 1038310-99-4(N-(3-methylpentan-2-yl)cyclopropanamine)
• 642407-45-2(2-BUTANAMINE, 2,3-DIMETHYL-N-PROPYL-)
• 642407-47-4(Cyclopropanemethanamine, N-(1,1,2-trimethylpropyl)-)
• 20437-19-8(2-azabicyclo[5.1.0]octane)
• 2738-06-9(n-ethyl-1,2-dimethylpropylamine)
• 852108-28-2(3-PENTANAMINE, N-ETHYL-2,4-DIMETHYL-)